IRIDEX Corp IRIX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $3.02
- Day Range
- $2.96–3.01
- 52-Week Range
- $1.31–3.65
- Bid/Ask
- $2.97 / $3.00
- Market Cap
- $48.86 Mil
- Volume/Avg
- 2,445 / 36,090
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.94
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 139
- Website
- https://www.iridex.com
Competitors
Valuation
|
Metric
|
IRIX
|
AFX
|
|---|---|---|
Price/Earnings (Normalized) | — | 30.47 |
Price/Book Value | 5.15 | 4.04 |
Price/Sales | 0.94 | 4.17 |
Price/Cash Flow | — | 23.18 |
Price/Earnings
IRIX
AFX
Financial Strength
|
Metric
|
IRIX
|
AFX
|
|---|---|---|
Quick Ratio | 1.29 | 2.41 |
Current Ratio | 2.12 | 3.40 |
Interest Coverage | — | 22.05 |
Quick Ratio
IRIX
AFX
Profitability
|
Metric
|
IRIX
|
AFX
|
|---|---|---|
Return on Assets (Normalized) | −21.80% | — |
Return on Equity (Normalized) | −60.65% | — |
Return on Invested Capital (Normalized) | −52.76% | — |
Return on Assets
IRIX
AFX
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Wfqbggyq | Fgjyxth | $182.7 Bil | |
SYK
| Stryker Corp | Gfynrbbbk | Shvsw | $124.6 Bil | |
MDT
| Medtronic PLC | Xwjktlc | Yxhbzm | $105.2 Bil | |
BSX
| Boston Scientific Corp | Tdhfmjkl | Tgvmndq | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Bskglvqm | Qhmxjv | $52.0 Bil | |
DXCM
| DexCom Inc | Mrkpvwbm | Hjc | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Nlhtytwvj | Zhj | $24.5 Bil | |
ALGN
| Align Technology Inc | Nybdtmsyl | Tmdlfnn | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Djhhkfxw | Nzytyr | $18.3 Bil | |
PODD
| Insulet Corp | Ptwbqbzyv | Rkmstn | $11.6 Bil |